Citadel Advisors - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 49 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$1,703,309
+45.9%
337,289
+45.3%
0.00%
Q2 2023$1,167,720
-42.5%
232,151
-29.7%
0.00%
Q1 2023$2,030,773
-67.9%
330,207
-31.0%
0.00%
-100.0%
Q4 2022$6,320,530
+332.3%
478,828
-2.8%
0.00%
Q3 2022$1,462,000
-25.3%
492,523
-8.1%
0.00%
Q2 2022$1,956,000
-11.7%
536,017
+49.9%
0.00%
Q1 2022$2,214,000
+36.2%
357,678
+78.2%
0.00%
Q4 2021$1,625,000
-66.6%
200,682
-38.5%
0.00%
-100.0%
Q3 2021$4,862,000
+62.2%
326,247
+36.6%
0.00%
Q2 2021$2,998,000238,9140.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$396,0000.12%
Sofinnova Investments, Inc. 142,635$482,0000.04%
INSPIRION WEALTH ADVISORS, LLC 22,075$75,0000.03%
Iron Gate Global Advisors LLC 14,641$49,0000.03%
REGENTATLANTIC CAPITAL LLC 18,245$62,0000.00%
Ellis Investment Partners, LLC 3,250$10,0000.00%
ADVANTAGE INVESTMENT MANAGEMENT, LLC 45$00.00%
Renaissance Technologies 91,569$309,0000.00%
BARCLAYS PLC 1$00.00%
D. E. Shaw & Co., Inc. 13,678$46,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders